Literature DB >> 25736871

MicroRNA in intervertebral disc degeneration.

Zheng Li1, Xin Yu, Jianxiong Shen, Matthew T V Chan, William Ka Kei Wu.   

Abstract

Aetiology of intervertebral disc degeneration (IDD) is complex, with genetic, developmental, biochemical and biomechanical factors contributing to the disease process. It is becoming obvious that epigenetic processes influence evolution of IDD as strongly as the genetic background. Deregulated phenotypes of nucleus pulposus cells, including differentiation, migration, proliferation and apoptosis, are involved in all stages of progression of human IDD. Non-coding RNAs, including microRNAs, have recently been recognized as important regulators of gene expression. Research into roles of microRNAs in IDD has been very active over the past 5 years. Our review summarizes current research enlightenment towards understanding roles of microRNAs in regulating nucleus pulposus cell functions in IDD. These exciting findings support the notion that specific modulation of microRNAs may represent an attractive approach for management of IDD.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25736871      PMCID: PMC6496566          DOI: 10.1111/cpr.12180

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  86 in total

1.  MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis.

Authors:  Kohei Nakata; Kenoki Ohuchida; Kazuhiro Mizumoto; Tadashi Kayashima; Naoki Ikenaga; Hiroshi Sakai; Cui Lin; Hayato Fujita; Takao Otsuka; Shinichi Aishima; Eishi Nagai; Yoshinao Oda; Masao Tanaka
Journal:  Surgery       Date:  2011-11       Impact factor: 3.982

2.  PDCD4 expression inversely correlated with miR-21 levels in gastric cancers.

Authors:  Zhang Cao; Jung Hwan Yoon; Suk Woo Nam; Jung Young Lee; Won Sang Park
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-03       Impact factor: 4.553

3.  Degenerative disc disease of herniated intervertebral discs is associated with extracellular matrix remodeling, vimentin-positive cells and cell death.

Authors:  Carla Loreto; Giuseppe Musumeci; Alessandro Castorina; Corrado Loreto; Giuseppa Martinez
Journal:  Ann Anat       Date:  2011-01-26       Impact factor: 2.698

Review 4.  MicroRNAs and cancer: past, present, and potential future.

Authors:  Kristen M Nelson; Glen J Weiss
Journal:  Mol Cancer Ther       Date:  2008-12       Impact factor: 6.261

5.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.

Authors:  Li Ma; Julie Teruya-Feldstein; Robert A Weinberg
Journal:  Nature       Date:  2007-09-26       Impact factor: 49.962

6.  Clinicopathologic significance of miR-10b expression in gastric carcinoma.

Authors:  Yuan-Yu Wang; Zai-Yuan Ye; Zhong-Sheng Zhao; Li Li; Yong-Xiang Wang; Hou-Quan Tao; Hui-Ju Wang; Xu-Jun He
Journal:  Hum Pathol       Date:  2013-01-23       Impact factor: 3.466

Review 7.  Intervertebral disc: anatomy-physiology-pathophysiology-treatment.

Authors:  P Prithvi Raj
Journal:  Pain Pract       Date:  2008 Jan-Feb       Impact factor: 3.183

Review 8.  miRNAs and cancer: an epigenetics view.

Authors:  Marcos Malumbres
Journal:  Mol Aspects Med       Date:  2012-07-04

Review 9.  miRNAs in human cancer.

Authors:  Thalia A Farazi; Jessica I Spitzer; Pavel Morozov; Thomas Tuschl
Journal:  J Pathol       Date:  2010-11-18       Impact factor: 7.996

10.  The role of leptin on the organization and expression of cytoskeleton elements in nucleus pulposus cells.

Authors:  Zheng Li; Jianxiong Shen; William Ka Kei Wu; Xin Yu; Jinqian Liang; Guixing Qiu; Jiaming Liu
Journal:  J Orthop Res       Date:  2013-01-17       Impact factor: 3.494

View more
  75 in total

Review 1.  microRNA deregulation in keloids: an opportunity for clinical intervention?

Authors:  Xin Yu; Zheng Li; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2015-10-21       Impact factor: 6.831

Review 2.  Circulating epigenetic biomarkers in melanoma.

Authors:  Yu Xin; Zheng Li; Matthew T V Chan; William Ka Kei Wu
Journal:  Tumour Biol       Date:  2015-12-11

Review 3.  New insights into MicroRNAs involves in drug resistance in diffuse large B cell lymphoma.

Authors:  Xin Yu; Zheng Li
Journal:  Am J Transl Res       Date:  2015-12-15       Impact factor: 4.060

4.  miR-211 promotes non-small cell lung cancer proliferation by targeting SRCIN1.

Authors:  Leiguang Ye; Hui Wang; Baogang Liu
Journal:  Tumour Biol       Date:  2015-08-16

5.  MicroRNA-346 functions as an oncogene in cutaneous squamous cell carcinoma.

Authors:  Bin Chen; Wenyan Pan; Xiaoxi Lin; Zhenzhen Hu; Yunbo Jin; Hui Chen; Gang Ma; Yajing Qiu; Lei Chang; Chen Hua; Yun Zou; Yang Gao; Hanru Ying; Dongze Lv
Journal:  Tumour Biol       Date:  2015-09-26

6.  miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.

Authors:  Shuguang Zhou; Bing Wang; Jun Hu; Yucheng Zhou; Mengzhen Jiang; Mingyu Wu; Liming Qin; Xuming Yang
Journal:  Tumour Biol       Date:  2016-01-13

7.  Mesenchymal stem cells-derived exosomes ameliorate nucleus pulposus cells apoptosis via delivering miR-142-3p: therapeutic potential for intervertebral disc degenerative diseases.

Authors:  Lifan Zhu; Yuhui Shi; Ling Liu; Huan Wang; Pengcheng Shen; Huilin Yang
Journal:  Cell Cycle       Date:  2020-06-17       Impact factor: 4.534

8.  MicroRNA-765 regulates neural stem cell proliferation and differentiation by modulating Hes1 expression.

Authors:  Siou Li; Weina Zhao; Qing Xu; Yang Yu; Changhao Yin
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

Review 9.  Long non-coding RNAs in nucleus pulposus cell function and intervertebral disc degeneration.

Authors:  Zheng Li; Xingye Li; Chong Chen; Shugang Li; Jianxiong Shen; Gary Tse; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2018-07-24       Impact factor: 6.831

10.  MiR-26a inhibits thyroid cancer cell proliferation by targeting ARPP19.

Authors:  Yanping Gong; Wenshuang Wu; Xiuhe Zou; Feng Liu; Tao Wei; Jingqiang Zhu
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.